Affiliation:
1. Perm State Medical University named after E.A. Wagner of the Ministry of Healthcare of the Russian Federation
2. Medical Unit № 1
3. Perm Regional Clinical Hospital
Abstract
The aimof the work is to describe the clinical case of formation, diagnosis and treatment of the acquired form of blood clotting factor VIII deficiency – of acquired hemophilia A.Material and methods. Patient R., 71 years, from April 2018, was found an acute hemorrhagic syndrome in the hematomic type of large hematomas manifested submandibular region, neck, chest, right breast, pubic and inguinal regions on the right, the anterior-medial surface of the left femur, anterior surface of left tibia. Standard laboratory tests, computed tomography of soft tissues of the neck, lungs, abdomen; coagulogram; blood clotting factors; inhibitor of factor VIII were evaluated in dynamics during the patient’s stay in the hospital; platelet aggregation function.Results. Typical gematomny type of bleeding, prolongation of coagulation indicators, the presence of the inhibitor factor VIII (7,0 BAA), the decrease in factor VIII (2 %) allowed diagnosis of acquired hemophilia A. Anti-inhibitory coagulant complex, fresh frozen plasma was successfully used for treatment. The patient is under observation in the regional Hematology center. The hematomas were not renewed.Conclusion. Our clinical observation demonstrates the features of the course, the algorithm of diagnosis and management of patients with of acquired hemophilia A.
Publisher
Publishing House ABV Press
Reference11 articles.
1. Ershov V.I., Gadaev I.Yu., Budanova D.A. i dr. Priobretennaya idiopaticheskaya gemofiliya s novoi missens-mutatsiei gena faktora VIII(His2026Arg): obzor literatury i klinicheskoe nablyudenie. Terapevticheskii arkhiv 2018;90(7):118–22. [Ershov V.I., Gadaev I.Yu., Budanova D.A. et al. Idiopathic acquired hemophilia with a new missense mutation of factor VIII gene (His2026Arg): literature review and clinical observation. Terapevticheskiy arkhiv = Therapeutic archive 2018;90(7):118–22. (In Russ.)].
2. Kruse-Jarres R., Kempton C.L., Baudo F. et al. Acquired hemophilia A: Updated review of evidence and treatment guidance. Am J Hematol 2017;92(7):695–705. DOI:10.1002/ajh.24777.
3. Kessler C.M., Ma A.D., Al-Mondhiry H.A. et al. Assessment of acquired hemophilia patient demographics in the United States: the hemostasis and thrombosis research society registry. Blood Coagul Fibrinolysis 2016;27(7):761–9. DOI:10.1097/MBC.0000000000000582.
4. Ewenstein B.M., Putnam K.G., Bohn R.L. Nonhemophilic inhibitors of coagulation. In: C.S. Kitchens, B.M. Alving, C.M. Kessler. Ed. Consultative hemostasis and thrombosis. Philadelphia, PA: W.B. Saunders, 2002. Rp.: 5–90.
5. Prasolov N.V., Bulanov A.Yu., Shulutko E.M., Orel E.B. Priobretennaya gemofiliya u pozhilykh patsientov. Klinicheskaya gerontologiya 2015;21(9–10): 16–24. [Prasolov N.V., Bulanov A.Yu., Shulutko E.M., Orel E.B. Acquired hemophilia in elderly patients. Klinicheskaya gerontologiya = Clinical gerontology 2015;21(9–10):16–24. (In Russ.)].